adibendan has been researched along with isoproterenol in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ebbert, M; Janssens, WJ; Leidig, A; Meuter, C; Peters, T; Wilffert, B; Wilhelm, D | 1 |
| Eschenhagen, T; Mende, U; Müller, FU; Neumann, J; Schmitz, W; Scholz, H | 1 |
2 other study(ies) available for adibendan and isoproterenol
| Article | Year |
|---|---|
In vitro pharmacology of R 80122, a novel phosphodiesterase inhibitor.
Topics: Action Potentials; Animals; Benzimidazoles; Carbachol; Female; Guinea Pigs; Heart Rate; Imidazoles; In Vitro Techniques; Isoproterenol; Male; Milrinone; Myocardial Contraction; Norepinephrine; Ouabain; Oxindoles; Papillary Muscles; Phosphodiesterase Inhibitors; Pyridones; Quinazolines; Stimulation, Chemical; Vasodilator Agents | 1992 |
Phosphodiesterase inhibition and positive inotropy in failing human myocardium.
Topics: Benzimidazoles; Cyclic AMP; Dose-Response Relationship, Drug; Drug Interactions; Heart; Humans; Imidazoles; Isoenzymes; Isometric Contraction; Isoproterenol; Myocardial Contraction; Myocardium; Organ Culture Techniques; Oxindoles; Phosphodiesterase Inhibitors; Phosphoric Diester Hydrolases; Piperazines; Pyridazines; Pyridones | 1992 |